These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 516000)

  • 1. Platelet hyperaggregability and the nephrotic syndrome.
    Remuzzi G; Mecca G; Marchesi D; Livio M; de Gaetano G; Donati MB; Silver MJ
    Thromb Res; 1979; 16(3-4):345-54. PubMed ID: 516000
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet hypersensitivity in the nephrotic syndrome.
    Remuzzi G; Marchesi D; Mecca G; de Gaetano G; Silver M
    Proc Eur Dial Transplant Assoc; 1979; 16():487-94. PubMed ID: 548992
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.
    Jackson CA; Greaves M; Patterson AD; Brown CB; Preston FE
    Br J Haematol; 1982 Sep; 52(1):69-77. PubMed ID: 6810912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration.
    Bennett A; Cameron JS
    Clin Nephrol; 1987 Apr; 27(4):182-8. PubMed ID: 3107859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of arachidonic acid by platelets in nephrotic syndrome.
    Schieppati A; Dodesini P; Benigni A; Massazza M; Mecca G; Remuzzi G; Livio M; de Gaetano G; Rossi EC
    Kidney Int; 1984 Apr; 25(4):671-6. PubMed ID: 6434788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced platelet function in glomerular renal disease.
    Bang NU; Trygstad W; Schroeder JE; Heidenreich RO; Csiscko BM
    J Lab Clin Med; 1973 May; 81(5):651-60. PubMed ID: 4121489
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome.
    Green RA; Russo EA; Greene RT; Kabel AL
    J Am Vet Med Assoc; 1985 Mar; 186(5):485-8. PubMed ID: 2982777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome.
    Machleidt C; Mettang T; Stärz E; Weber J; Risler T; Kuhlmann U
    Kidney Int; 1989 Dec; 36(6):1119-24. PubMed ID: 2532267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
    Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation and dipyridamole therapy in nephrotics.
    Chen WY; Chen TJ; Yen TS; Hsieh BS; Tsai TJ; Hsu HC
    Taiwan Yi Xue Hui Za Zhi; 1982 Jan; 81(1):31-42. PubMed ID: 6954237
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet aggregation in homozygous beta thalassaemia.
    Rai R; Pati H; Arya LS; Saraya AK
    Indian J Med Res; 1987 Jul; 86():61-4. PubMed ID: 3121504
    [No Abstract]   [Full Text] [Related]  

  • 13. The simultaneous effect of albumin bound fatty acids on platelets and endothelial cells.
    Nordøy A; Svensson B
    Thromb Res; 1979; 15(1-2):215-26. PubMed ID: 384597
    [No Abstract]   [Full Text] [Related]  

  • 14. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen.
    Nyman D
    Thromb Res; 1977 May; 10(5):743-51. PubMed ID: 882960
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergism between platelet aggregating agents: the role of the arachidonate pathway.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Res; 1977 Nov; 11(5):567-80. PubMed ID: 337565
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole blood platelet aggregation in uremic dogs.
    Forsythe LT; Jackson ML; Meric SM
    Am J Vet Res; 1989 Oct; 50(10):1754-7. PubMed ID: 2802308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide deficiency associated with increased platelet count and aggregability in nephrotic syndrome.
    Eneman B; Freson K; van den Heuvel L; van Hoyweghen E; Collard L; Vande Walle J; van Geet C; Levtchenko E
    J Thromb Haemost; 2015 May; 13(5):755-67. PubMed ID: 25758343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole blood platelet aggregation in dogs with liver disease.
    Willis SE; Jackson ML; Meric SM; Rousseaux CG
    Am J Vet Res; 1989 Nov; 50(11):1893-7. PubMed ID: 2619120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of hypercholesterolaemia by HMG-CoA reductase inhibitor (Pravastatin) improved platelet hyperaggregability in nephrotic patients.
    Yashiro M; Muso E; Shio H; Sasayama S
    Nephrol Dial Transplant; 1994; 9(12):1842-3. PubMed ID: 7708285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.